IgG4-Related Disease
Disease State Hub
Featured
07/10/2026
Anthony Calabro, MA
In a phase 3 randomized controlled trial of adults with active IgG4-related disease, weekly subcutaneous obexelimab significantly prolonged time to first flare requiring rescue therapy vs placebo and...
07/10/2026
07/02/2026
Anthony Calabro, MA
Glucocorticoids are widely used in IgG4-related disease, but long-term management can be challenging in a chronic, relapsing fibroinflammatory condition. This quiz reviews a key treatment consideration...
07/02/2026
06/25/2026
Anthony Calabro, MA
IgG4-related disease is unlikely to be the first diagnosis suspected in primary care, but PCPs may be the first clinicians to recognize the atypical, recurrent, mass-like, or multiorgan patterns that should...
06/25/2026
Interactive Features
07/02/2026
Anthony Calabro, MA
Glucocorticoids are widely used in IgG4-related disease, but long-term management can be challenging in a chronic, relapsing fibroinflammatory condition. This quiz reviews a key treatment consideration...
07/02/2026
05/19/2025
Anthony Calabro, MA
How familiar are you with the most common lung complication in immunoglobulin G4–related disease? Test your knowledge with this quiz to find out!
05/19/2025
11/18/2024
Miranda Manier, BA
While pediatric and adult immunoglobulin G4-related disease share some similarities, there are important differences in how they present, especially in organ involvement and diagnostic criteria. Test your...
11/18/2024
10/30/2024
According to a recent review article, 58% of patients with immunoglobulin G4-related disease (IgG4-RD) had damage in at least one organ at diagnosis. Take this quiz to find out which organ is most often...
10/30/2024
11/22/2015
Researchers recently investigated inebilizumab as a potential treatment option for patients with immunoglobulin G4-related disease. Test your understanding of the findings!
11/22/2015
